AAPL   264.92 (-3.14%)
FB   186.13 (-1.91%)
MSFT   156.59 (-1.01%)
GOOGL   1,277.85 (-2.82%)
AMZN   1,836.08 (-2.56%)
CGC   18.03 (-2.22%)
NVDA   258.41 (+2.30%)
BABA   199.92 (-2.49%)
MU   50.94 (+0.71%)
GE   10.12 (-2.60%)
TSLA   627.38 (-7.60%)
AMD   43.45 (-1.27%)
ACB   1.36 (-6.21%)
F   6.77 (-2.87%)
NFLX   360.20 (-3.10%)
BAC   27.90 (-4.22%)
GILD   67.96 (-6.47%)
AAPL   264.92 (-3.14%)
FB   186.13 (-1.91%)
MSFT   156.59 (-1.01%)
GOOGL   1,277.85 (-2.82%)
AMZN   1,836.08 (-2.56%)
CGC   18.03 (-2.22%)
NVDA   258.41 (+2.30%)
BABA   199.92 (-2.49%)
MU   50.94 (+0.71%)
GE   10.12 (-2.60%)
TSLA   627.38 (-7.60%)
AMD   43.45 (-1.27%)
ACB   1.36 (-6.21%)
F   6.77 (-2.87%)
NFLX   360.20 (-3.10%)
BAC   27.90 (-4.22%)
GILD   67.96 (-6.47%)
AAPL   264.92 (-3.14%)
FB   186.13 (-1.91%)
MSFT   156.59 (-1.01%)
GOOGL   1,277.85 (-2.82%)
AMZN   1,836.08 (-2.56%)
CGC   18.03 (-2.22%)
NVDA   258.41 (+2.30%)
BABA   199.92 (-2.49%)
MU   50.94 (+0.71%)
GE   10.12 (-2.60%)
TSLA   627.38 (-7.60%)
AMD   43.45 (-1.27%)
ACB   1.36 (-6.21%)
F   6.77 (-2.87%)
NFLX   360.20 (-3.10%)
BAC   27.90 (-4.22%)
GILD   67.96 (-6.47%)
AAPL   264.92 (-3.14%)
FB   186.13 (-1.91%)
MSFT   156.59 (-1.01%)
GOOGL   1,277.85 (-2.82%)
AMZN   1,836.08 (-2.56%)
CGC   18.03 (-2.22%)
NVDA   258.41 (+2.30%)
BABA   199.92 (-2.49%)
MU   50.94 (+0.71%)
GE   10.12 (-2.60%)
TSLA   627.38 (-7.60%)
AMD   43.45 (-1.27%)
ACB   1.36 (-6.21%)
F   6.77 (-2.87%)
NFLX   360.20 (-3.10%)
BAC   27.90 (-4.22%)
GILD   67.96 (-6.47%)
Log in

Abeona Therapeutics News Headlines (NASDAQ:ABEO)

$3.06
-0.25 (-7.56 %)
(As of 02/28/2020 11:04 AM ET)
Today's Range
$3.05
Now: $3.06
$3.42
50-Day Range
$2.17
MA: $2.87
$4.08
52-Week Range
$1.46
Now: $3.06
$8.41
Volume447,419 shs
Average Volume1.77 million shs
Market Capitalization$156.46 million
P/E RatioN/A
Dividend YieldN/A
Beta2.16

Headlines

Abeona Therapeutics (NASDAQ ABEO) News Headlines

Source:
DateHeadline
Abeona Therapeutics to Present at the 9th Annual SVB Leerink Global Healthcare ConferenceAbeona Therapeutics to Present at the 9th Annual SVB Leerink Global Healthcare Conference
finance.yahoo.com - February 26 at 12:43 PM
 Analysts Anticipate Abeona Therapeutics Inc (NASDAQ:ABEO) Will Post Earnings of -$0.29 Per Share Analysts Anticipate Abeona Therapeutics Inc (NASDAQ:ABEO) Will Post Earnings of -$0.29 Per Share
www.americanbankingnews.com - February 24 at 3:16 AM
Is the Options Market Predicting a Spike in Abeona (ABEO) Stock?Is the Options Market Predicting a Spike in Abeona (ABEO) Stock?
finance.yahoo.com - February 21 at 1:45 PM
Gene Therapy Products Market 2020-2026 Revenue Analysis || Leading Players are Adverum, Arbutus Biopharma, Audentes Therapeutics, AveXis Inc.Gene Therapy Products Market 2020-2026 Revenue Analysis || Leading Players are Adverum, Arbutus Biopharma, Audentes Therapeutics, AveXis Inc.
www.marketwatch.com - February 20 at 1:21 PM
Will Abeona Therapeutics Continue to Surge Higher?Will Abeona Therapeutics Continue to Surge Higher?
www.nasdaq.com - February 18 at 8:05 AM
Abeona Therapeutics Inc.: Abeona Therapeutics Announces Positive Interim Data from MPS III Gene Therapy Programs Presented at WORLDSymposiumAbeona Therapeutics Inc.: Abeona Therapeutics Announces Positive Interim Data from MPS III Gene Therapy Programs Presented at WORLDSymposium
www.finanznachrichten.de - February 12 at 7:03 PM
Abeona Therapeutics Announces Positive Interim Data from MPS III Gene Therapy Programs Presented at WORLDSymposium™Abeona Therapeutics Announces Positive Interim Data from MPS III Gene Therapy Programs Presented at WORLDSymposium™
finance.yahoo.com - February 12 at 7:03 PM
FY2019 Earnings Forecast for Abeona Therapeutics Inc (NASDAQ:ABEO) Issued By Svb LeerinkFY2019 Earnings Forecast for Abeona Therapeutics Inc (NASDAQ:ABEO) Issued By Svb Leerink
www.americanbankingnews.com - February 12 at 6:43 AM
Abeona Therapeutics (ABEO) Moves to Buy: Rationale Behind the UpgradeAbeona Therapeutics (ABEO) Moves to Buy: Rationale Behind the Upgrade
www.nasdaq.com - February 11 at 1:25 PM
Abeona Therapeutics (NASDAQ:ABEO) Earns Buy Rating from Analysts at Leerink SwannAbeona Therapeutics (NASDAQ:ABEO) Earns Buy Rating from Analysts at Leerink Swann
www.americanbankingnews.com - February 11 at 11:17 AM
Abeona Therapeutics Inc (NASDAQ: ABEO)Abeona Therapeutics Inc (NASDAQ: ABEO)
www.benzinga.com - February 10 at 7:47 PM
Cantor upgrades Adverum on positive ADVM-022 dataCantor upgrades Adverum on positive ADVM-022 data
seekingalpha.com - February 10 at 9:47 AM
Abeona Therapeutics (NASDAQ:ABEO) Coverage Initiated at Svb LeerinkAbeona Therapeutics (NASDAQ:ABEO) Coverage Initiated at Svb Leerink
www.americanbankingnews.com - February 10 at 8:25 AM
Abeona Therapeutics Inc (NASDAQ:ABEO) Receives Consensus Recommendation of "Hold" from AnalystsAbeona Therapeutics Inc (NASDAQ:ABEO) Receives Consensus Recommendation of "Hold" from Analysts
www.americanbankingnews.com - February 5 at 12:22 PM
Abeona Therapeutics Inc.: Abeona Therapeutics Announces Participation in Inaugural World Congress on Epidermolysis BullosaAbeona Therapeutics Inc.: Abeona Therapeutics Announces Participation in Inaugural World Congress on Epidermolysis Bullosa
www.finanznachrichten.de - January 21 at 5:54 PM
Abeona Therapeutics Announces Participation in Inaugural World Congress on Epidermolysis BullosaAbeona Therapeutics Announces Participation in Inaugural World Congress on Epidermolysis Bullosa
finance.yahoo.com - January 21 at 5:54 PM
Abeona Therapeutics Announces Issuance of U.S. Patent for AIM™ CapsidsAbeona Therapeutics Announces Issuance of U.S. Patent for AIM™ Capsids
finance.yahoo.com - January 15 at 2:19 PM
Abeona launches pivotal study of RDEB gene-corrected cell therapyAbeona launches pivotal study of RDEB gene-corrected cell therapy
seekingalpha.com - January 13 at 5:20 PM
Abeona Therapeutics Initiates Pivotal Phase 3 Clinical Trial Evaluating EB-101 Gene Therapy for Recessive Dystrophic Epidermolysis BullosaAbeona Therapeutics Initiates Pivotal Phase 3 Clinical Trial Evaluating EB-101 Gene Therapy for Recessive Dystrophic Epidermolysis Bullosa
finance.yahoo.com - January 13 at 5:20 PM
Abeona chief scientific officer resigningAbeona chief scientific officer resigning
seekingalpha.com - January 8 at 8:27 PM
Insider Weekends: A Lost Decade Of Insider Buying By Dr. FrostInsider Weekends: A Lost Decade Of Insider Buying By Dr. Frost
seekingalpha.com - January 6 at 3:49 PM
Whats Ahead For Abeona TherapeuticsWhat's Ahead For Abeona Therapeutics
seekingalpha.com - January 3 at 4:58 PM
Insider Buying: The Abeona Therapeutics Inc. (NASDAQ:ABEO) Just Bought US$500k Worth Of SharesInsider Buying: The Abeona Therapeutics Inc. (NASDAQ:ABEO) Just Bought US$500k Worth Of Shares
finance.yahoo.com - January 2 at 1:45 PM
Insider Buying: The Abeona Therapeutics Inc. (NASDAQ:ABEO)  Just Bought US$500k Worth Of SharesInsider Buying: The Abeona Therapeutics Inc. (NASDAQ:ABEO) Just Bought US$500k Worth Of Shares
finance.yahoo.com - January 2 at 1:45 PM
DEADLINE ALERT - Abeona Therapeutics Inc. (ABEO) - Bronstein, Gewirtz & Grossman, LLC Reminds Investors With Losses Exceeding $100K of Class Action and Lead Plaintiff Deadline: January 2, 2019DEADLINE ALERT - Abeona Therapeutics Inc. (ABEO) - Bronstein, Gewirtz & Grossman, LLC Reminds Investors With Losses Exceeding $100K of Class Action and Lead Plaintiff Deadline: January 2, 2019
finance.yahoo.com - January 2 at 1:45 PM
FINAL DEADLINE TODAY: The Schall Law Firm Announces the Filing of a Class Action Lawsuit Against Abeona Therapeutics Inc. and Encourages Investors with Losses in Excess of $200,000 to Contact the FirmFINAL DEADLINE TODAY: The Schall Law Firm Announces the Filing of a Class Action Lawsuit Against Abeona Therapeutics Inc. and Encourages Investors with Losses in Excess of $200,000 to Contact the Firm
finance.yahoo.com - January 2 at 1:45 PM
THURSDAY DEADLINE ALERT: The Schall Law Firm Announces it is Investigating Claims Against Abeona Therapeutics Inc. and Encourages Investors with Losses to Contact the FirmTHURSDAY DEADLINE ALERT: The Schall Law Firm Announces it is Investigating Claims Against Abeona Therapeutics Inc. and Encourages Investors with Losses to Contact the Firm
finance.yahoo.com - January 2 at 1:45 PM
THURSDAY DEADLINE: The Schall Law Firm Announces the Filing of a Class Action Lawsuit Against Abeona Therapeutics Inc. and Encourages Investors with Losses in Excess of $200,000 to Contact the FirmTHURSDAY DEADLINE: The Schall Law Firm Announces the Filing of a Class Action Lawsuit Against Abeona Therapeutics Inc. and Encourages Investors with Losses in Excess of $200,000 to Contact the Firm
finance.yahoo.com - December 31 at 3:24 PM
ABEONA EQUITY LOSS ALERT: ROSEN, A LEADING LAW FIRM, Reminds Abeona Therapeutics Inc. Investors of Important Thursday Deadline in Securities Class Action - ABEOABEONA EQUITY LOSS ALERT: ROSEN, A LEADING LAW FIRM, Reminds Abeona Therapeutics Inc. Investors of Important Thursday Deadline in Securities Class Action - ABEO
www.benzinga.com - December 31 at 1:53 PM
FINAL DEADLINE: ROSEN, NATIONAL TRIAL LAWYERS, Reminds Abeona Therapeutics Inc. Investors of Important January 2nd Deadline in Securities Class ActionFINAL DEADLINE: ROSEN, NATIONAL TRIAL LAWYERS, Reminds Abeona Therapeutics Inc. Investors of Important January 2nd Deadline in Securities Class Action
www.prnewswire.com - December 28 at 11:37 AM
DEADLINE ALERT: Bragar Eagel & Squire, P.C. Reminds Investors That a Class Action Lawsuit Has Been Filed Against Abeona Therapeutics, Inc. and Encourages Investors to Contact the FirmDEADLINE ALERT: Bragar Eagel & Squire, P.C. Reminds Investors That a Class Action Lawsuit Has Been Filed Against Abeona Therapeutics, Inc. and Encourages Investors to Contact the Firm
finance.yahoo.com - December 27 at 9:55 PM
6-Day Deadline Alert: The Schall Law Firm Announces the Filing of a Class Action Lawsuit Against Abeona Therapeutics Inc. and Encourages Investors with Losses in Excess of $200,000 to Contact the Firm6-Day Deadline Alert: The Schall Law Firm Announces the Filing of a Class Action Lawsuit Against Abeona Therapeutics Inc. and Encourages Investors with Losses in Excess of $200,000 to Contact the Firm
finance.yahoo.com - December 27 at 9:55 PM
Abeona Therapeutics: Speculative Buy After FinancingAbeona Therapeutics: Speculative Buy After Financing
seekingalpha.com - December 24 at 11:47 PM
SHAREHOLDER ACTION ALERT: The Schall Law Firm Announces the Filing of a Class Action Lawsuit Against Abeona Therapeutics Inc. and Encourages Investors with Losses in Excess of $200,000 to Contact the FirmSHAREHOLDER ACTION ALERT: The Schall Law Firm Announces the Filing of a Class Action Lawsuit Against Abeona Therapeutics Inc. and Encourages Investors with Losses in Excess of $200,000 to Contact the Firm
finance.yahoo.com - December 24 at 6:46 PM
Abeona Announces Closing of $103.5 Million Underwritten Public Offering and Full Exercise of Underwriters’ Option to Purchase Additional SharesAbeona Announces Closing of $103.5 Million Underwritten Public Offering and Full Exercise of Underwriters’ Option to Purchase Additional Shares
finance.yahoo.com - December 24 at 1:46 PM
ROSEN, A TOP RANKED LAW FIRM, Reminds Abeona Therapeutics Inc. Investors of Important Deadline in Securities Class Action – ABEOROSEN, A TOP RANKED LAW FIRM, Reminds Abeona Therapeutics Inc. Investors of Important Deadline in Securities Class Action – ABEO
finance.yahoo.com - December 24 at 1:46 PM
BRIEF-Abeona Therapeutics Announces Public Offering Of Common Stock And Pre Funded WarrantsBRIEF-Abeona Therapeutics Announces Public Offering Of Common Stock And Pre Funded Warrants
www.msn.com - December 20 at 11:48 PM
Are Options Traders Betting On A Big Move In Abeona Therapeutics (ABEO) Stock?Are Options Traders Betting On A Big Move In Abeona Therapeutics (ABEO) Stock?
www.msn.com - December 20 at 11:48 PM
FINAL DEADLINE APPROACHING: The Schall Law Firm Announces the Filing of a Class Action Lawsuit Against Abeona Therapeutics Inc. and Encourages Investors with Losses in Excess of $200,000 to Contact the FirmFINAL DEADLINE APPROACHING: The Schall Law Firm Announces the Filing of a Class Action Lawsuit Against Abeona Therapeutics Inc. and Encourages Investors with Losses in Excess of $200,000 to Contact the Firm
finance.yahoo.com - December 20 at 6:45 PM
Abeona Therapeutics Inc.: Abeona Therapeutics Receives European Medicines Agency PRIME Designation for ABO-102 Gene Therapy in MPS IIIAAbeona Therapeutics Inc.: Abeona Therapeutics Receives European Medicines Agency PRIME Designation for ABO-102 Gene Therapy in MPS IIIA
www.finanznachrichten.de - December 20 at 1:44 PM
Abeona Announces Pricing of Public Offering of Common Stock and Pre‑Funded WarrantsAbeona Announces Pricing of Public Offering of Common Stock and Pre‑Funded Warrants
www.globenewswire.com - December 20 at 1:44 PM
Abeona down 39% after pricing equity offeringAbeona down 39% after pricing equity offering
seekingalpha.com - December 20 at 1:44 PM
Heres Why Abeona Therapeutics Fell as Much as 43.8% TodayHere's Why Abeona Therapeutics Fell as Much as 43.8% Today
www.fool.com - December 20 at 1:44 PM
Abeona Therapeutics Receives European Medicines Agency PRIME Designation for ABO-102 Gene Therapy in MPS IIIAAbeona Therapeutics Receives European Medicines Agency PRIME Designation for ABO-102 Gene Therapy in MPS IIIA
finance.yahoo.com - December 20 at 8:44 AM
Abeona Therapeutics Inc.: Abeona Therapeutics Announces Public Offering of Common Stock and Pre Funded WarrantsAbeona Therapeutics Inc.: Abeona Therapeutics Announces Public Offering of Common Stock and Pre Funded Warrants
www.finanznachrichten.de - December 19 at 6:18 PM
Abeona Therapeutics Announces Public Offering of Common Stock and Pre Funded WarrantsAbeona Therapeutics Announces Public Offering of Common Stock and Pre Funded Warrants
finance.yahoo.com - December 19 at 6:18 PM
ABEO NOTICE: Pawar Law Group Reminds Investors of JANUARY 2 Deadline in Securities Class Action Lawsuit Against Abeona Therapeutics Inc.– ABEOABEO NOTICE: Pawar Law Group Reminds Investors of JANUARY 2 Deadline in Securities Class Action Lawsuit Against Abeona Therapeutics Inc.– ABEO
www.benzinga.com - December 18 at 4:35 PM
Bronstein, Gewirtz & Grossman, LLC Reminds Investors of Class Action Against Abeona Therapeutics Inc. (ABEO), AZZ, Inc. (AZZ) & Twitter, Inc. (TWTR)Bronstein, Gewirtz & Grossman, LLC Reminds Investors of Class Action Against Abeona Therapeutics Inc. (ABEO), AZZ, Inc. (AZZ) & Twitter, Inc. (TWTR)
finance.yahoo.com - December 16 at 1:44 PM
ABEO LOSS ALERT: TOP RANKED ROSEN LAW FIRM Reminds Abeona Therapeutics Inc. Investors of Important Deadline in Securities Class Action – ABEOABEO LOSS ALERT: TOP RANKED ROSEN LAW FIRM Reminds Abeona Therapeutics Inc. Investors of Important Deadline in Securities Class Action – ABEO
finance.yahoo.com - December 15 at 12:26 PM
INVESTOR ALERT: The Schall Law Firm Announces the Filing of a Class Action Lawsuit Against Abeona Therapeutics Inc. and Encourages Investors with Losses in Excess of $200,000 to Contact the FirmINVESTOR ALERT: The Schall Law Firm Announces the Filing of a Class Action Lawsuit Against Abeona Therapeutics Inc. and Encourages Investors with Losses in Excess of $200,000 to Contact the Firm
finance.yahoo.com - December 13 at 7:43 PM
This page was last updated on 2/28/2020 by MarketBeat.com Staff

Featured Article: Depreciation

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.

Yahoo Gemini Pixel